0000080424FalseFalseFalseFalseFalse00000804242020-07-012021-03-310000080424us-gaap:CommonStockMember2020-07-012021-03-310000080424exch:XNYS2020-07-012021-03-310000080424pg:A2.000due2021Domain2020-07-012021-03-310000080424pg:A2.000due2022Domain2020-07-012021-03-310000080424pg:A1.125due2023Domain2020-07-012021-03-310000080424pg:A0.500due2024Domain2020-07-012021-03-310000080424pg:A0.625due2024Domain2020-07-012021-03-310000080424pg:A1.375due2025Domain2020-07-012021-03-310000080424pg:A4.875EURdueMay2027Domain2020-07-012021-03-310000080424pg:A1.200due2028Domain2020-07-012021-03-310000080424pg:A1.250due2029Domain2020-07-012021-03-310000080424pg:A1.800due2029Domain2020-07-012021-03-310000080424pg:A6.250GBPdueJanuary2030Domain2020-07-012021-03-310000080424pg:A5.250GBPdueJanuary2033Domain2020-07-012021-03-310000080424pg:A1.875due2038Domain2020-07-012021-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported)April 20, 2021

THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 

OhioOH1-43431-0411980
(State of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
One Procter & Gamble Plaza,CincinnatiOH
One Procter & Gamble Plaza, Cincinnati, Ohio45202
(Address of principal executive offices)(Zip Code)
(513) 983-1100
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨

FalseWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨FalseSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨FalsePre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨FalsePre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, without Par ValuePGNYSE
2.000% Notes due 2021PG21NYSE
2.000% Notes due 2022PG22BNYSE
1.125% Notes due 2023PG23ANYSE
0.500% Notes due 2024PG24ANYSE
0.625% Notes due 2024PG24BNYSE
1.375% Notes due 2025PG25NYSE
4.875% EUR notes due May 2027PG27ANYSE
1.200% Notes due 2028PG28NYSE
1.250% Notes due 2029PG29BNYSE
1.800% Notes due 2029PG29ANYSE
6.250% GBP notes due January 2030PG30NYSE
5.250% GBP notes due January 2033PG33NYSE
1.875% Notes due 2038PG38NYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨ False
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On April 20, 2021, The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended March 31, 2021. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition."

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
Exhibit NumberDescription
99.1
News Release by The Procter & Gamble Company dated April 20, 2021.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
THE PROCTER & GAMBLE COMPANY
By/s/ SANDRA T. LANE
Sandra T. Lane, Assistant Secretary
4/20/2021
  
EXHIBIT(S)
99.1 News Release by The Procter & Gamble Company dated April 20, 2021.